Disclosure of HIV test results in HIV-infected adolescents in the Aconda program (CePReF, CHU Yopougon) in Abidjan, Côte d’Ivoire: The Project PRADO-CI Meless GD. , Aka-Dago-Akribi H., Cacou C., Aka AE., Oga AC., Bouah B., Kouao L, Messou E., Tanoh FE, Moh C., Timité-Konan M. and Leroy V. for the PRADO-CI Group 23 BP 2485 ABIDJAN 23 Tel : 23-52-52-53/ 23-46-25-51 Fax: 23-52-52-53 Email : acondavs@ aviso.ci 1
15
Embed
Disclosure of HIV test results in HIV-infected adolescents in the Aconda program (CePReF, CHU Yopougon) in Abidjan, Côte d’Ivoire: The Project PRADO-CI.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Disclosure of HIV test results in HIV-infected adolescents
in the Aconda program (CePReF, CHU Yopougon) in Abidjan, Côte d’Ivoire: The Project PRADO-CI Meless GD., Aka-Dago-Akribi H., Cacou C., Aka AE., Oga AC.,
Bouah B., Kouao L, Messou E., Tanoh FE, Moh C.,
Timité-Konan M. and Leroy V. for the PRADO-CI Group
23 BP 2485 ABIDJAN 23 Tel : 23-52-52-53 / 23-46-25-51 Fax : 23-52-52-53 Email : [email protected]
1
• With antiretroviral treatment (ART) access in HIV-infected children, HIV-infected adolescents are an emerging population
•
• Adolescence is a vulnerable period – Emotional and behavioral disorders– Problem of treatment adherence– Problem of program retention– Problem of mutiple previous ART regimens
2
Background (1)
• An HIV diagnosis is a life-changing event
• Especially in adolescents, the disclosure of the HIV test result – Is essential for HIV prevention– May accentuate behavioral disorders– May improve ART adherence– Could impact on ART outcomes
3
Background (2)
3
To study the prevalence of the disclosure of HIV test result and its association with their baseline characteristics in ART-treated adolescents in Abidjan, Côte d’Ivoire
4
Objective
4
Methods (1)
• Since 2004: Aconda Program in Côte d’Ivoire
– Pediatric care, with free HIV diagnosis and ART
access in HIV-infected children
– Funding: EGPAF/PEPFAR
– Collaboration: Inserm U897/ISPED, Bordeaux
– Current active file: 2244 HIV+ children (1000 on ART)
5
Methods (2)
• The PRADO-CI Study
– Cross-sectional study nested in the Aconda active file
– Psycho-social and behavioral difficulties and their
determinants in adolescents
– Funding: Sidaction
6
Methods (3)
• Inclusion criteria
– HIV-infected adolescents
– Aged 13 to 21 years,
– Seen at least once in 2009
– in two urban centers of the Aconda program in Abidjan
7
Methods (4)
• Data collection: medical records
– Demographic (age, sex ...)
– Drugs: Cotrimoxazole prophylaxis, ART
– HIV disclosure documented in chart
• Formal: provided by medical team
• Informal: through another source
– % and correlates of disclosure, logistic regression
8
9
Results (1)
9
Baseline description (N=230)
n %
Gender Female 104 45
Age 13-15 years 131 57
16-18 years 70 30
19-21 years 29 13
Cotrimoxazole prophylaxis Yes 116 61
No 73 39
On ART Yes 211 92
Experienced ART modification Yes 122 73
Informed of their HIV status (N=194) Yes 63 33
No 131 67
Univariate logistic regression correlates of documented HIV disclosure (N=194)